Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells

被引:101
作者
Johansson, S
Lindholm, P
Gullbo, J
Larsson, P
Bohlin, L
Claeson, P
机构
[1] Univ Uppsala, Ctr Biomed, Dept Med Chem, Div Pharmacognosy, S-75123 Uppsala, Sweden
[2] Univ Uppsala Hosp, Div Clin Pharmacol, S-75185 Uppsala, Sweden
关键词
cytotoxicity drug screening; digitalis glycosides; digitonin; digitoxigenin; digitoxin; digoxin; lanatoside C; ouabain; proscillaridin A; tumor cell lines;
D O I
10.1097/00001813-200106000-00009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The saponin digitonin, the aglycone digitoxigenin and five cardiac glycosides were evaluated for cytotoxicity using primary cultures of tumor cells from patients and a human cell line panel (representing different cytotoxic drug-resistance patterns). Of these seven compounds, proscillaridin A was the most potent (IC50: 6.4-76 nM), followed by digitoxin, and then ouabain, digoxin, lanatoside C, digitoxigenin and digitonin, Correlation analysis of the log IC50 values for the cell lines in the panel showed that compound cytotoxicity was only slightly influenced by resistance mechanisms that involved P-glycoprotein, topoisomerase II, multidrug resistance-associated protein and glutathione-mediated drug resistance. Digitoxin and digoxin expressed selective toxicity against solid tumor cells from patients, while proscillaridin A expressed no selective toxicity against either solid or hematological tumor cells. The results revealed marked differences in cytotoxicity between the cardiac glycosides, both in potency and selectivity, and modes of action for cytotoxicity that differ from that of commonly used anticancer drugs. [(C) 2001 Lippincott Williams & Wilkins.].
引用
收藏
页码:475 / 483
页数:9
相关论文
共 35 条
  • [1] [Anonymous], 1985, Goodman and Gilman's the pharmacological basis of therapeutics
  • [2] SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN
    BOYD, MR
    PAULI, KD
    [J]. DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) : 91 - 109
  • [3] CASSADY J. M., 1981, NATURAL PRODUCTS MED, P93
  • [4] Fractionation protocol for the isolation of polypeptides from plant biomass
    Claeson, P
    Göransson, U
    Johansson, S
    Luijendijk, T
    Bohlin, L
    [J]. JOURNAL OF NATURAL PRODUCTS, 1998, 61 (01): : 77 - 81
  • [5] COVE DH, 1979, LANCET, V2, P204
  • [6] CYTOTOXIC DRUG-SENSITIVITY TESTING OF TUMOR-CELLS FROM PATIENTS WITH OVARIAN-CARCINOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA)
    CSOKA, K
    LARSSON, R
    THOLANDER, B
    GERDIN, E
    DELATORRE, M
    NYGREN, P
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 54 (02) : 163 - 170
  • [7] Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance
    Dhar, S
    Nygren, P
    Csoka, K
    Botling, J
    Nilsson, K
    Larsson, R
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (06) : 888 - 896
  • [8] A nonclonogenic cytotoxicity assay using primary cultures of patient tumor cells for anticancer drug screening
    Dhar, S
    Gullbo, J
    Nilsson, K
    Nygren, P
    Larsson, R
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 1998, 3 (03) : 207 - 216
  • [9] EFFECT OF DIGOXIN ON DNA-SYNTHESIS AND CELL VIABILITY IN HUMAN-BREAST TUMOR-TISSUE IN ORGAN-CULTURE
    FALCONER, IR
    BERESFORD, AM
    JONES, A
    VACEK, AT
    [J]. CHEMOTHERAPY, 1983, 29 (05) : 368 - 372
  • [10] Fridborg H, 1996, J Exp Ther Oncol, V1, P286